|
Market Closed -
OTC Markets
11:13:09 2026-04-02 EDT
|
5-day change | 1st Jan Change | ||
| 82.75 USD | +4.81% |
|
-.--% | +1.78% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORION OYJ | Other Pharmaceuticals | +4.81% | -.--% | +1.78% | +1.78% | +100.21% | 13.05B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ORNBV Stock
- ORINF Stock
- Charts Orion Oyj
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
